Menveo meningococcal
Selected indexed studies
- Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y. (Expert Rev Vaccines, 2011) [PMID:21162617]
- Meningococcal quadrivalent (serogroups A, C, w135, and y) conjugate vaccine (Menveo): in adolescents and adults. (BioDrugs, 2010) [PMID:20795751]
- Meningococcal glycoconjugate vaccines. (Hum Vaccin, 2011) [PMID:21178398]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Bexsero® chronicle. (2014) pubmed
- Meningococcal conjugate vaccines. (2005) pubmed
- Meningococcal glycoconjugate vaccines. (2011) pubmed
- Meningococcal vaccines. (2007) pubmed
- Meningococcal immunology. (2003) pubmed
- Meningococcal vaccines in China. (2021) pubmed
- Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y. (2011) pubmed
- Meningococcal quadrivalent (serogroups A, C, w135, and y) conjugate vaccine (Menveo): in adolescents and adults. (2010) pubmed
- A new conjugate meningococcal vaccine (Menveo). (2010) pubmed
- Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report. (2012) pubmed